NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

EXAS

Exact Sciences Corp

May 16 • 04:00PM ET

56.42

Dollar change +0.25
Percentage change 0.45	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB XBI VXF VBK FBT IWR SCHM VHT IWP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.50	Insider Own	1.53%	Shs Outstand	188.59M	Perf Week	9.28%
Market Cap	10.64B	Forward P/E	143.13	EPS next Y	0.39	Insider Trans	0.00%	Shs Float	185.81M	Perf Month	33.51%
Income	-1019.84M	PEG	-	EPS next Q	-0.12	Inst Own	97.01%	Short Float	5.45%	Perf Quarter	14.42%
Sales	2.83B	P/S	3.76	EPS this Y	92.25%	Inst Trans	3.09%	Short Ratio	3.76	Perf Half Y	12.48%
Book/sh	12.71	P/B	4.44	EPS next Y	190.99%	ROA	-16.87%	Short Interest	10.12M	Perf Year	4.48%
Cash/sh	4.17	P/C	13.54	EPS next 5Y	-	ROE	-36.89%	52W Range	39.97 - 72.83	Perf YTD	0.41%
Dividend Est.	-	P/FCF	54.82	EPS past 5Y	-54.24%	ROI	-20.82%	52W High	-22.53%	Beta	0.98
Dividend TTM	-	Quick Ratio	2.38	Sales past 5Y	27.39%	Gross Margin	69.57%	52W Low	41.16%	ATR (14)	2.52
Dividend Ex-Date	-	Current Ratio	2.73	EPS Y/Y TTM	-315.25%	Oper. Margin	-6.75%	RSI (14)	72.40	Volatility	4.68% 4.75%
Employees	7000	Debt/Eq	1.06	Sales Y/Y TTM	11.57%	Profit Margin	-36.06%	Recom	1.40	Target Price	69.33
Option/Short	Yes / Yes	LT Debt/Eq	1.04	EPS Q/Q	10.37%	Payout	-	Rel Volume	1.18	Prev Close	56.17
Sales Surprise	2.63%	EPS Surprise	-44.04%	Sales Q/Q	10.86%	Earnings	May 01 AMC	Avg Volume	2.69M	Price	56.42
SMA20	13.19%	SMA50	21.12%	SMA200	0.54%	Trades		Volume	3,175,676	Change	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$60
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50

Show Previous Ratings

May-14-25 04:51AM	2 Brilliant Stocks to Buy With $200 and Hold for 5 Years (Motley Fool)
May-12-25 10:00AM	Exact Sciences Earns 2025 Great Place To Work Certification (Business Wire)
08:44AM	Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? (Zacks)
May-07-25 04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-05-25 12:55PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
12:52PM	Loading…
May-02-25 12:52PM	Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling (Seeking Alpha) +9.31%
12:51PM	Q1 2025 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
07:28AM	EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised (Zacks)
06:00AM	Exact Sciences to Participate in May Investor Conference (Business Wire)
03:18AM	Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ... (GuruFocus.com)
May-01-25 08:47PM	Exact Sciences Corporation (EXAS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:35PM	Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:36PM	Exact Sciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback. (Investor's Business Daily)
04:05PM	Exact Sciences Announces First-Quarter 2025 Results (Business Wire)
08:50AM	Loading…
Apr-30-25 08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Apr-29-25 06:59AM	Exact Sciences to Highlight Cologuard Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025 (Business Wire)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-24-25 10:01AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
08:08AM	Exact Sciences (EXAS): Among Billionaire George Soros' Small-Cap Stocks with Huge Upside Potential (Insider Monkey)
05:03AM	2 Reasons to Like EXAS (and 1 Not So Much) (StockStory)
Apr-23-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-22-25 06:00AM	Exact Sciences Launches the Oncodetect Molecular Residual Disease Test (Business Wire)
Apr-17-25 04:15PM	The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. (Investor's Business Daily)
Apr-15-25 05:02AM	Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers (StockStory)
Apr-14-25 03:00PM	Tap Into the Silver Economy Boom With These Aging Demographics Stocks (Zacks)
06:00AM	JAMA Oncology Publication Strengthens Evidence for Oncotype DX Test Reliability Across Racial and Ethnic Groups (Business Wire)
Apr-01-25 06:00AM	Exact Sciences Schedules First Quarter 2025 Earnings Call (Business Wire)
Mar-31-25 06:00AM	Exact Sciences Launches the Cologuard Plus Test, Transforming Colorectal Cancer Screening (Business Wire)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	Loading…
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 12:20AM	PGIM Jennison Mid-Cap Growth Fund Q4 2024 Commentary (Seeking Alpha)
Mar-27-25 09:06AM	Should You Retain Exact Sciences Stock in Your Portfolio Now? (Zacks)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-24-25 12:35PM	Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
Mar-21-25 11:30AM	Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-20-25 09:03AM	1 Healthcare Stock on Our Watchlist and 2 to Turn Down (StockStory)
08:50AM	Should You Invest in Exact Sciences Corp. (EXAS)? (InsiderMonkey)
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-14-25 09:01AM	1 Stock Under $50 to Target This Week and 2 to Turn Down (StockStory)
Mar-12-25 09:00AM	Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner (Business Wire)
Mar-04-25 09:00AM	Heres What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) (Insider Monkey)
Mar-03-25 06:48PM	Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now (Insider Monkey)
Feb-24-25 12:00PM	2 Stocks Down 59% and 34% to Buy and Hold (Motley Fool)
06:00AM	Exact Sciences to Participate in March Investor Conferences (Business Wire)
Feb-20-25 07:01PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
01:40PM	Why Exact Sciences (EXAS) Shares Are Trading Lower Today (StockStory)
08:25AM	Q4 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:12AM	Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:30AM	Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-19-25 05:25PM	Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:42PM	Exact Sciences: Q4 Earnings Snapshot (Associated Press Finance)
04:22PM	Exact Sciencess (NASDAQ:EXAS) Q4: Beats On Revenue (StockStory)
04:05PM	Exact Sciences Announces Fourth Quarter 2024 Results (Business Wire)
Feb-18-25 08:03AM	Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-12-25 05:57PM	Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts (Yahoo Finance)
10:00AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-06-25 08:30AM	Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members (GlobeNewswire)
Feb-03-25 06:00AM	Exact Sciences Schedules Fourth Quarter 2024 Earnings Call (Business Wire)
Jan-22-25 07:39AM	Exact Sciences post positive results from MRD trial (Clinical Trials Arena)
Jan-21-25 05:05PM	New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients (Business Wire)
05:05PM	Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium (Business Wire)
04:03PM	Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone (Investor's Business Daily)
Jan-17-25 06:15AM	Why Exact Sciences (EXAS) Is Crashing? (Insider Monkey)
Jan-16-25 09:15PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) -5.75%
04:05PM	Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?' (Investor's Business Daily)
05:22AM	2 Healthcare Stocks to Buy Hand Over Fist in January (Motley Fool)
Jan-12-25 07:00PM	Exact Sciences Announces Preliminary Fourth Quarter 2024 Results (Business Wire)
Jan-03-25 06:46AM	Exact Sciences price target raised to $70 from $60 at Evercore ISI (TipRanks)
Jan-02-25 06:00AM	Exact Sciences to Participate in J.P. Morgan Healthcare Conference (Business Wire)
Nov-26-24 07:27PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +9.00%
01:24PM	Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) (Benzinga)
06:00AM	Exact Sciences to Participate in December Investor Conferences (Business Wire)
Nov-25-24 05:35PM	Exact Sciences Advances Breast Cancer Care with the Oncotype DX test and Genomic Profiling Research at SABCS 2024 (Business Wire)
Nov-19-24 06:57PM	Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +8.84%
Nov-15-24 07:47AM	Exact Sciences showcases early cancer detection test data at AACR meeting (Clinical Trials Arena)
Nov-13-24 01:00PM	Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy (Business Wire)
Nov-11-24 09:55AM	Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter (Insider Monkey)
Nov-08-24 06:46AM	Exact Sciences forecast cut shocks analysts (MedTech Dive)
Nov-07-24 04:05PM	Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
10:05AM	Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
Nov-06-24 04:04PM	Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? (Investor's Business Daily) -23.48%
11:47AM	Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount (Investopedia)
10:22AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
10:13AM	Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point (Benzinga)
06:55AM	Q3 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:24AM	Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
12:02AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Nov-05-24 08:42PM	Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook (Investor's Business Daily)
07:45PM	Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript (Motley Fool)
05:30PM	Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:29PM	Exact Sciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Announces Third-Quarter 2024 Results (Business Wire)
Nov-01-24 06:00AM	Exact Sciences to Participate in November Investor Conference (Business Wire)
Oct-29-24 12:00PM	Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Oct-27-24 12:00PM	Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement (Business Wire)
Oct-17-24 08:00AM	Can This Beaten-Down Cathie Wood Stock Bounce Back? (Motley Fool)
Oct-16-24 10:34AM	Exact Sciences Corporation (EXAS) Bounced Back in Q3 (Insider Monkey)
Oct-09-24 03:36PM	Exact Sciences Corp (EXAS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Oct-08-24 06:00AM	Exact Sciences Schedules Third Quarter 2024 Earnings Call (Business Wire)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bloomer Aaron	EVP, Chief Financial Officer	Apr 15 '25	Option Exercise	0.00	24,460	0	19,340	Apr 17 04:30 PM
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM
Baranick Brian	EVP, GM, Precision Oncology	Oct 08 '24	Sale	70.00	929	65,030	12,758	Oct 09 05:00 PM
Baranick Brian	Officer	Oct 08 '24	Proposed Sale	70.00	929	65,030		Oct 08 01:27 PM
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '24	Option Exercise	0.00	2,712	0	15,991	Aug 06 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience